Cargando…
Molecular assays for the detection of prostate tumor derived nucleic acids in peripheral blood
BACKGROUND: Prostate cancer is the second leading cause of cancer mortality in American men. Although serum PSA testing is widely used for early detection, more specific prognostic tests are needed to guide treatment decisions. Recently, the enumeration of circulating prostate epithelial cells has b...
Autores principales: | Jost, Matthias, Day, John R, Slaughter, Ryan, Koreckij, Theodore D, Gonzales, Deanna, Kinnunen, Martin, Groskopf, Jack, Rittenhouse, Harry G, Vessella, Robert L, Reynolds, Mark A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903503/ https://www.ncbi.nlm.nih.gov/pubmed/20598135 http://dx.doi.org/10.1186/1476-4598-9-174 |
Ejemplares similares
-
Inhibition of CCL2 Signaling in Combination with Docetaxel Treatment Has Profound Inhibitory Effects on Prostate Cancer Growth in Bone
por: Kirk, Peter S., et al.
Publicado: (2013) -
Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis
por: Koreckij, T, et al.
Publicado: (2009) -
Molecular assays for the detection of microRNAs in prostate cancer
por: Siva, Amara C, et al.
Publicado: (2009) -
Evaluation of an Epigenetic Assay for Predicting Repeat Prostate Biopsy Outcome in African American Men
por: Waterhouse, Robert L., et al.
Publicado: (2019) -
Cost-effectiveness of an urinary biomarker panel in combination with MRI for prostate cancer diagnosis
por: Govers, Tim M., et al.
Publicado: (2023)